{"id":71003,"date":"2017-05-23T13:14:35","date_gmt":"2017-05-23T13:14:35","guid":{"rendered":"http:\/\/humanitasnet-new.local\/malattie\/sindromul-antifosfolipidic-safl\/"},"modified":"2025-01-13T02:51:50","modified_gmt":"2025-01-13T02:51:50","slug":"sindromul-antifosfolipidic-safl","status":"publish","type":"disease","link":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/","title":{"rendered":"Sindromul antifosfolipidic (SAFL)"},"content":{"rendered":"<p>Sindromul antifosfolipidic (SAFL) este o afec\u021biune care se manifest\u0103 clinic ca tromboz\u0103 venoas\u0103 sau arterial\u0103 recurent\u0103 \u0219i \/ sau pierderea fetal\u0103. Apare atunci c&acirc;nd sistemul imunitar atac\u0103 &icirc;n mod eronat unele dintre proteinele normale din s&acirc;nge. Sindromul antifosfolipidic poate provoca formarea cheagurilor de s&acirc;nge &icirc;n interiorul arterelor sau al venelor. De asemenea, poate provoca complica\u021bii ale sarcinii, cum ar fi avortul spontan \u0219i na\u0219terea unui f\u0103t mort.<br \/>\nSindromul antifosfolipidic poate determina formarea cheagurilor de s&acirc;nge la venele piciorului (tromboza venoas\u0103 profund\u0103), dar \u0219i &icirc;n organe cum ar fi rinichii sau pl\u0103m&acirc;nii, chiar \u0219i un cheag &icirc;n creier care poate provoca un accident vascular cerebral.<\/p>\n<h2>\nSimptome<\/h2>\n<p>Simptomele sindromului antifosfolipidic pot fi:<\/p>\n<p>Pierderea repetat\u0103 a sarcinilor sau na\u0219terea fe\u021bilor mor\u021bi \u0219i alte complica\u021bii ale sarcinii, cum ar fi na\u0219terile premature \u0219i hipertensiunea arterial\u0103 &icirc;n timpul sarcinii (preeclampsie)<br \/>\nCheaguri de s&acirc;nge la nivelul picioarelor (tromboz\u0103 venoas\u0103 profund\u0103 sau TVP) care se pot deplasa la pl\u0103m&acirc;ni (embolie pulmonar\u0103)<br \/>\nAccident vascular cerebral<br \/>\nCheaguri de s&acirc;nge la arterele bra\u021belor sau picioarelor (tromboz\u0103 arterial\u0103 periferic\u0103).<br \/>\nDar, de asemenea, simptome neurologice, erup\u021bii cutanate, boli cardiovasculare \u0219i s&acirc;nger\u0103ri.<\/p>\n<h2>\nCauze<\/h2>\n<p>&Icirc;n sindromul antifosfolipidic, organismul produce &icirc;n mod eronat anticorpi &icirc;mpotriva proteinelor care leag\u0103 fosfolipidele, un tip de gr\u0103sime prezent &icirc;n s&acirc;nge, care joac\u0103 un rol-cheie &icirc;n coagulare. Anticorpii sunt proteine specializate care atac\u0103 &icirc;n mod normal invadatorii din corp, cum ar fi virusurile \u0219i bacteriile. C&acirc;nd anticorpii atac\u0103 proteinele care leag\u0103 fosfolipidele, s&acirc;ngele se poate coagula anormal.<br \/>\nUnii factori precum infec\u021biile, medicamentele \u0219i predispozi\u021biile genetice sunt asociate cu dezvoltarea anticorpilor antifosfolipidici.<\/p>\n<h2>\nFactori de risc<\/h2>\n<p>Factorii de risc pentru sindromul antifosfolipidic includ:<\/p>\n<p>Afec\u021biunile autoimune, cum ar fi lupus eritematos sistemic sau sindromul Sjogren<br \/>\nPrezen\u021ba anumitor infec\u021bii, cum ar fi sifilisul, HIV \/ SIDA, hepatita C sau boala Lyme<br \/>\nAdministrarea de anumite medicamente, cum ar fi hidralazina pentru hipertensiunea arterial\u0103, chinidina care regleaz\u0103 ritmul cardiac, medicamentul anti-convulsii fenitoin\u0103 (Dilantin) \u0219i antibioticul amoxicilin\u0103<br \/>\nExisten\u021ba unui membru al familiei cu sindrom antifosfolipidic.<\/p>\n<h2>\nComplica\u021bii<\/h2>\n<p>&Icirc;n func\u021bie de organul afectat de cheagul de s&acirc;nge \u0219i de c&acirc;t de sever\u0103 este obstruc\u021bia fluxului sanguin &icirc;n organul respectiv, sindromul antifosfolipid netratat poate duce la leziuni permanente sau deces. Complica\u021biile pot include:<br \/>\nInsuficien\u021b\u0103 renal\u0103<br \/>\nAccident vascular cerebral<br \/>\nProbleme cardiovasculare<br \/>\nAfec\u021biuni pulmonare<br \/>\nComplica\u021bii &icirc;n sarcin\u0103<\/p>\n<h2>\nPrevenirea<\/h2>\n<p>Dac\u0103 ave\u021bi anticorpi antifosfolipidici, dar nu folosi\u021bi medicamente anticoagulante, lua\u021bi urm\u0103toarele m\u0103suri de precau\u021bie:<br \/>\nInforma\u021bi medicul c\u0103 ave\u021bi anticorpi antifosfolipidici<br \/>\nLua\u021bi m\u0103suri pentru a ajuta la prevenirea trombozei venoase profunde, dac\u0103 nu v\u0103 pute\u021bi mi\u0219ca din cauza interven\u021biilor chirurgicale sau din alte motive medicale.<br \/>\nNu fuma\u021bi.<br \/>\nLua\u021bi m\u0103suri, cum ar fi sc\u0103derea nivelului de colesterol, pentru a preveni un atac de cord sau un accident vascular cerebral.<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-71003","disease","type-disease","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sindromul antifosfolipidic (SAFL) - Humanitas.net<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sindromul antifosfolipidic (SAFL) - Humanitas.net\" \/>\n<meta property=\"og:description\" content=\"Sindromul antifosfolipidic (SAFL) este o afec\u021biune care se manifest\u0103 clinic ca tromboz\u0103 venoas\u0103 sau arterial\u0103 recurent\u0103 \u0219i \/ sau pierderea fetal\u0103. Apare atunci c&acirc;nd sistemul imunitar atac\u0103 &icirc;n mod eronat unele dintre proteinele normale din s&acirc;nge. Sindromul antifosfolipidic poate provoca formarea cheagurilor de s&acirc;nge &icirc;n interiorul arterelor sau al venelor. De asemenea, poate provoca complica\u021bii [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/\" \/>\n<meta property=\"og:site_name\" content=\"Humanitas.net\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HumanitasInternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T02:51:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@humanitasmilano\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/\",\"name\":\"Sindromul antifosfolipidic (SAFL) - Humanitas.net\",\"isPartOf\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\"},\"datePublished\":\"2017-05-23T13:14:35+00:00\",\"dateModified\":\"2025-01-13T02:51:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Malattie\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sindromul antifosfolipidic (SAFL)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"name\":\"Humanitas.net\",\"description\":\"Humanitas Hospital\",\"publisher\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\",\"name\":\"Humanitas\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"contentUrl\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"width\":1,\"height\":1,\"caption\":\"Humanitas\"},\"image\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/HumanitasInternational\/\",\"https:\/\/x.com\/humanitasmilano\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sindromul antifosfolipidic (SAFL) - Humanitas.net","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"ro_RO","og_type":"article","og_title":"Sindromul antifosfolipidic (SAFL) - Humanitas.net","og_description":"Sindromul antifosfolipidic (SAFL) este o afec\u021biune care se manifest\u0103 clinic ca tromboz\u0103 venoas\u0103 sau arterial\u0103 recurent\u0103 \u0219i \/ sau pierderea fetal\u0103. Apare atunci c&acirc;nd sistemul imunitar atac\u0103 &icirc;n mod eronat unele dintre proteinele normale din s&acirc;nge. Sindromul antifosfolipidic poate provoca formarea cheagurilor de s&acirc;nge &icirc;n interiorul arterelor sau al venelor. De asemenea, poate provoca complica\u021bii [&hellip;]","og_url":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/","og_site_name":"Humanitas.net","article_publisher":"https:\/\/www.facebook.com\/HumanitasInternational\/","article_modified_time":"2025-01-13T02:51:50+00:00","twitter_card":"summary_large_image","twitter_site":"@humanitasmilano","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/","name":"Sindromul antifosfolipidic (SAFL) - Humanitas.net","isPartOf":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website"},"datePublished":"2017-05-23T13:14:35+00:00","dateModified":"2025-01-13T02:51:50+00:00","breadcrumb":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/diseases\/sindromul-antifosfolipidic-safl\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/"},{"@type":"ListItem","position":2,"name":"Malattie","item":"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/"},{"@type":"ListItem","position":3,"name":"Sindromul antifosfolipidic (SAFL)"}]},{"@type":"WebSite","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website","url":"https:\/\/humanitas-net.humweb.webiz.team\/","name":"Humanitas.net","description":"Humanitas Hospital","publisher":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization","name":"Humanitas","url":"https:\/\/humanitas-net.humweb.webiz.team\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","contentUrl":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","width":1,"height":1,"caption":"Humanitas"},"image":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HumanitasInternational\/","https:\/\/x.com\/humanitasmilano"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/wp-json\/wp\/v2\/disease\/71003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/wp-json\/wp\/v2\/disease"}],"about":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/wp-json\/wp\/v2\/types\/disease"}],"wp:attachment":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/wp-json\/wp\/v2\/media?parent=71003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}